Venous thromboembolism (VTE) represents both a significant health threat for at-risk patients and a financial burden. Meanwhile, provider organizations that fail to focus on and prevent VTE from ...

Provider Recommendations for Phase I Clinical Trials Within a Shared Decision-Making Model in Phase I Cancer Clinical Trial Discussions Venous Thromboembolism Prevention in the Ambulatory Cancer ...

A new national benchmark in pediatric venous thromboembolism (VTE) care Being designated as the first pediatric NBCA ...

Venous thromboembolism is a common complication in patients with malignant disease. One of the environments in which patients can present with symptomatic thromboembolic disease is in the ...

Methods In a double-blind, multicenter trial, we randomly assigned 1233 patients with venous thromboembolism who had undergone six months of anticoagulant therapy to extended secondary prevention with ...

Venous thromboembolism is a frequent complication of total hip or total knee arthroplasty, with serious clinical and economic consequences. It is largely preventable with adherence to evidence-based ...

In total hip or total knee arthroplasty, hypercoagulability typically begins on the operating table and a hypercoagulable state persists for up to 3 months after surgery. For that reason, it is ...

Please provide your email address to receive an email when new articles are posted on . The proportion of patients receiving low-dose aspirin increased from 7.65% in 2012 to 55.29% in 2022. A low-dose ...

Atrial fibrillation (AF), which affects approximately 3-6 million people in the United States, is a risk factor for thromboembolic events including stroke, cardiovascular events, and death. This ...

Now reported in the Journal are the results of an international, multiplatform, randomized clinical trial that combined data from patients who were enrolled in one conventional randomized trial (ACTIV ...

Expanding access to timely, evidence-based blood clot care in community settings Being recognized as the inaugural ...